Clinical Supplements

Early Clinical Experience with Desvenlafaxine Publication Date: December 2009 Supported by: Pfizer Inc.

Exploring Novel Treatment Options: Cognitive Decline in Alzheimer’s Disease Publication Date: January 2010 Supported by: Pamlab LLC.

Generic Substitution for Psychotropic Drugs: Questions and Answers Publication Date: September 2009 Supported by: Wyeth Pharmaceuticals

Other Clinical Supplements Available By Disease State

Addictive Disorders	Malingering
Alcohol-Related Disorders	Miscellaneous
Anxiety Disorders	Mood Disorders
Attention-Deficit/Hyperactivity Disorder	Movement Disorders
Autism Spectrum Disorders	Neurodegenerative Disorders
Bipolar Disorders	Neuropathy
Body Dysmorphic Disorder	Parkinson’s Disease
Brain Imaging	Personality Disorders
Chronic Pain	Pharmacologic Treatments
Dementia	Postpartum Depression
Depression	Psychosis
Eating Disorders	Schizophrenic Disorders
Epilepsy	Sexual Dysfunction
Fibromyalgia	Sleep Disorders
Impulse-Control Disorders	Stroke
Irritable Bowel Syndrome	Treatment Adherence